Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed, Refractory Multiple Myeloma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT06659770
What this trial is testing

A Real-World Observational Study: Zevorcabtagene Autoleucel Injection in Patients with Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma
CARsgen Therapeutics Co., Ltd. 200
Large-scale testing (Phase 3)Study completedNCT00452569
What this trial is testing

Efficacy and Safety Study of 3 Thalidomide Doses for the Treatment of Relapsed Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 499
Early research (Phase 1)Study completedNCT04543305
What this trial is testing

PRT1419 in Patients With Relapsed/Refractory Hematologic Malignancies

Who this might be right for
Multiple MyelomaAcute Myeloid LeukemiaNon Hodgkin Lymphoma+1 more
Prelude Therapeutics Incorporated 16
Not applicableStudy completedNCT06592222
What this trial is testing

Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma as Compared With Standard of Care Therapies

Who this might be right for
Multiple Myeloma
Pfizer 4
Testing effectiveness (Phase 2)Study completedNCT00010283
What this trial is testing

Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Fred Hutchinson Cancer Center
Early research (Phase 1)Study completedNCT04754100
What this trial is testing

AgenT-797 in Participants With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma
MiNK Therapeutics 13
Testing effectiveness (Phase 2)Study completedNCT01903811
What this trial is testing

S1304, Carfilzomib and Dexamethasone for Treating Patients With Relapsed or Refractory Myeloma

Who this might be right for
Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
SWOG Cancer Research Network 143
Testing effectiveness (Phase 2)Study completedNCT00882063
What this trial is testing

Study To Evaluate Safety and Efficacy of P276-00 in Subjects With Refractory Multiple Myeloma

Who this might be right for
Relapsed and/or Refractory Multiple Myeloma
Piramal Enterprises Limited 19
Testing effectiveness (Phase 2)Study completedNCT00908232
What this trial is testing

Treatment With Velcade (Bortezomib) Plus Dexamethasone (VD) or VD Plus Cyclophosphamide or VD Plus Lenalidomide in Patients With Multiple Myeloma Stabilized After 4 Cycles of VD

Who this might be right for
Multiple Myeloma
Janssen-Cilag International NV 163
Early research (Phase 1)UnknownNCT05346198
What this trial is testing

Evaluate CART-BCMA in Patients With Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Shanghai Simnova Biotechnology Co.,Ltd. 15
Testing effectiveness (Phase 2)Study completedNCT00248430
What this trial is testing

Donor White Blood Cell Infusions and Interleukin-2 in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed Advanced Lymphoid Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+1 more
Fred Hutchinson Cancer Center 20
Testing effectiveness (Phase 2)Ended earlyNCT05427812
What this trial is testing

Phase 1/2 Study of ISB 1442 in Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma
Ichnos Sciences SA 29
Testing effectiveness (Phase 2)UnknownNCT04891744
What this trial is testing

Selinexor in Combination With Thalidomide and Dexamethasone in RRMM

Who this might be right for
Multiple Myeloma
Li Zheng 48
Large-scale testing (Phase 3)Looking for participantsNCT07452198
What this trial is testing

GR1803 Injection Versus Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Genrix (Shanghai) Biopharmaceutical Co., Ltd. 358
Testing effectiveness (Phase 2)Study completedNCT01148108
What this trial is testing

Study of Canfosfamide in Refractory or Relapsed Mantle Cell, Diffuse Large B Cell Lymphoma and Multiple Myeloma

Who this might be right for
Mantle Cell LymphomaB Cell LymphomaMultiple Myeloma
Telik 14
Testing effectiveness (Phase 2)Ended earlyNCT06655818
What this trial is testing

Sub-study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Dostarlimab (GSK4057190) in Participants With RRMM

Who this might be right for
Relapsed/Refractory Multiple Myeloma
GlaxoSmithKline 4
Very early researchNot Yet RecruitingNCT07322159
What this trial is testing

IASO206 in Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma (RRMM)
Institute of Hematology & Blood Diseases Hospital, China 12
Early research (Phase 1)Ended earlyNCT00590603
What this trial is testing

Trisenox, Ascorbic Acid and Bortezomib in Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Duke University 25
Early research (Phase 1)Study completedNCT04557150
What this trial is testing

A Study Evaluating the Safety and Pharmacokinetics of Escalating Doses of Forimtamig in Participants With Relapsed or Refractory Multiple Myeloma (r/r MM)

Who this might be right for
Multiple Myeloma
Hoffmann-La Roche 225
Testing effectiveness (Phase 2)Study completedNCT00365287
What this trial is testing

Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer

Who this might be right for
Breast CancerKidney CancerLeukemia+3 more
Masonic Cancer Center, University of Minnesota 148
Next Page